Company Filing History:
Years Active: 1985-1991
Title: Innovations by David Riddell: A Journey of Therapeutic Advancements
Introduction
David Riddell is a notable inventor based in Billericay, GB. With a strong commitment to innovation, he has been instrumental in the development of several therapeutic compounds. Over his career, he has secured a total of 4 patents, showcasing his significant contributions to the field of medicinal chemistry.
Latest Patents
Among David's latest inventions are his patents on isoquinolinones and pyrrolophthalazines. The isoquinolinones patent involves therapeutically useful derivatives characterized by specific chemical formulas, where different groups represent various organic structures that assist in promoting health benefits. Similarly, his work on pyrrolophthalazines encapsulates a range of derivatives designed for therapeutic applications. The relevance of these compounds positions David as a key player in advancing medicinal chemistry.
Career Highlights
David Riddell has forged a career that stands out in the pharmaceutical sector, specifically through his association with May & Baker, Ltd. His innovative outlook and extensive research have culminated in the creation of valuable therapeutic solutions that benefit both the medical community and patients alike.
Collaborations
Throughout his career, David has collaborated with talented peers, including Michael J Ashton and Garry Fenton. These collaborations have allowed for the sharing of ideas and expertise, ultimately leading to the successful development of groundbreaking therapies.
Conclusion
In conclusion, David Riddell's inventive spirit and dedication to innovation are evident in his four patents, particularly in the realms of isoquinolinones and pyrrolophthalazines. As an influential member of May & Baker, Ltd., he continues to contribute significantly to the field of therapeutics, making strides that could lead to impactful medical advancements.